Mycenax Biotech Inc. (TPEX: 4726)
45.80
-1.70 (-3.58%)
Sep 10, 2024, 1:30 PM CST
Mycenax Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 462.03 | 519.27 | 1,323 | 286.93 | 291.14 | 193.67 |
Short-Term Investments | 17.04 | 148.42 | 16.12 | - | - | 83.56 |
Cash & Short-Term Investments | 479.06 | 667.69 | 1,339 | 286.93 | 291.14 | 277.23 |
Cash Growth | -47.42% | -50.15% | 366.84% | -1.45% | 5.02% | -2.09% |
Accounts Receivable | 118.61 | 58.53 | 81.32 | 320.84 | 169.03 | 126.38 |
Other Receivables | 5.5 | 4.69 | 3.09 | 11.33 | 5.51 | 1.83 |
Receivables | 124.11 | 63.22 | 84.41 | 332.17 | 174.54 | 128.21 |
Inventory | 99.64 | 112.33 | 246.72 | 173.3 | 84.85 | 56.12 |
Prepaid Expenses | 85.59 | 83.25 | 103.22 | 89.28 | 23.82 | 24.24 |
Other Current Assets | 197.42 | 171.53 | 149.95 | 15.73 | 2.16 | 9.15 |
Total Current Assets | 985.82 | 1,098 | 1,924 | 897.41 | 576.51 | 494.96 |
Property, Plant & Equipment | 1,779 | 1,847 | 1,978 | 1,351 | 786.73 | 592.84 |
Long-Term Investments | 184.72 | 190.81 | 199.51 | 109.59 | 191.81 | 149.31 |
Goodwill | 23.92 | 23.92 | 23.92 | 23.92 | 23.92 | 23.92 |
Other Intangible Assets | 16.21 | 18.98 | 25.93 | 33.71 | 36.72 | 50.93 |
Long-Term Deferred Tax Assets | 95.76 | 95.49 | 89.72 | 81.11 | 83.45 | 79.71 |
Other Long-Term Assets | 545.37 | 495.85 | 211.93 | 642.46 | 53.41 | 16.33 |
Total Assets | 3,631 | 3,770 | 4,453 | 3,139 | 1,753 | 1,408 |
Accounts Payable | 70.73 | 44.05 | 52.52 | 54.68 | 40.31 | 24.7 |
Accrued Expenses | 69.15 | 104.88 | 104.21 | 96.4 | 66.6 | 51.22 |
Short-Term Debt | - | - | 100 | 50 | 100 | - |
Current Portion of Long-Term Debt | 122.16 | 125.92 | 105.88 | 15.6 | - | - |
Current Portion of Leases | 33.84 | 30.57 | 37.28 | 28.59 | 24.33 | 13.62 |
Current Income Taxes Payable | - | - | - | - | 0.65 | - |
Current Unearned Revenue | 252.46 | 187.28 | 142.28 | 152.12 | 125.9 | 91.69 |
Other Current Liabilities | 90.03 | 260.72 | 92.57 | 142.69 | 66.99 | 50.69 |
Total Current Liabilities | 638.37 | 753.42 | 634.73 | 540.07 | 424.78 | 231.92 |
Long-Term Debt | 706.88 | 530.4 | 656.32 | 474.4 | - | - |
Long-Term Leases | 57.7 | 39.39 | 56.37 | 176.06 | 72.28 | 33.18 |
Long-Term Deferred Tax Liabilities | - | - | - | 3.75 | 6.68 | 3.81 |
Other Long-Term Liabilities | - | - | - | 38.07 | 37.14 | 37.14 |
Total Liabilities | 1,403 | 1,323 | 1,347 | 1,232 | 540.89 | 306.04 |
Common Stock | 2,058 | 2,059 | 2,053 | 1,533 | 1,282 | 1,280 |
Additional Paid-In Capital | 401.08 | 1,074 | 1,468 | 576.95 | 53.11 | 260.91 |
Retained Earnings | -237.23 | -682.64 | -406.83 | -254.34 | -207.23 | -473.31 |
Comprensive Income & Other | 5.85 | -3.32 | -8.8 | 50.72 | 83.41 | 34.81 |
Shareholders' Equity | 2,228 | 2,447 | 3,106 | 1,907 | 1,212 | 1,102 |
Total Liabilities & Equity | 3,631 | 3,770 | 4,453 | 3,139 | 1,753 | 1,408 |
Total Debt | 920.58 | 726.28 | 955.85 | 744.64 | 196.61 | 46.8 |
Net Cash (Debt) | -441.51 | -58.59 | 383.63 | -457.72 | 94.53 | 230.43 |
Net Cash Growth | - | - | - | - | -58.98% | -18.62% |
Net Cash Per Share | -2.15 | -0.29 | 2.32 | -3.08 | 0.73 | 1.83 |
Filing Date Shares Outstanding | 205.82 | 205.89 | 205.31 | 153.33 | 128.24 | 127.96 |
Total Common Shares Outstanding | 205.82 | 205.89 | 205.31 | 153.33 | 128.24 | 127.96 |
Working Capital | 347.45 | 344.59 | 1,289 | 357.34 | 151.73 | 263.04 |
Book Value Per Share | 10.82 | 11.89 | 15.13 | 12.43 | 9.45 | 8.61 |
Tangible Book Value | 2,188 | 2,404 | 3,056 | 1,849 | 1,151 | 1,027 |
Tangible Book Value Per Share | 10.63 | 11.68 | 14.88 | 12.06 | 8.98 | 8.03 |
Buildings | 792.86 | 792.86 | 791.68 | - | - | - |
Machinery | 1,601 | 1,603 | 1,575 | 837.57 | 688.02 | 573.33 |
Construction In Progress | 143.7 | 106.85 | 3.35 | 624.35 | 260.37 | 164.56 |
Leasehold Improvements | 317.34 | 317.34 | 307.77 | 276.23 | 246.21 | 236.3 |
Source: S&P Capital IQ. Standard template. Financial Sources.